magnesium sulfate has been researched along with Apoplexy in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (45.00) | 29.6817 |
| 2010's | 18 (45.00) | 24.3611 |
| 2020's | 4 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conwit, R; Eckstein, M; Hamilton, S; Liebeskind, DS; Naidech, AM; Sanossian, N; Saver, JL; Sharma, L; Shkirkova, K; Stratton, S; Villablanca, JP | 1 |
| da Silva Costa, F; Fenn, S; Mol, BW; Palmer, KR; Reddy, M; Rolnik, DL; Wallace, EM | 1 |
| Bechler, K; Conwit, R; Eckstein, M; Hamilton, S; Liebeskind, DS; Pratt, F; Sanossian, N; Saver, JL; Shkirkova, K; Starkman, S; Stratton, S | 1 |
| Abdollahi, M; Ahmadi, A; Barreto, GE; Ganjali, S; Gheini, M; Mojtahedzadeh, M; Najafi, A; Panahi, Y; Rajaee, SM; Sahebkar, A; Sharifzadeh, M | 1 |
| Conwit, R; Eckstein, M; Hamilton, S; Liebeskind, D; Pratt, F; Restrepo, L; Sanossian, N; Saver, JL; Sharma, L; Shkirkova, K; Starkman, S; Stratton, S; Valdes-Sueiras, M | 1 |
| Lingam, I; Robertson, NJ | 1 |
| Lin, WX; Luo, R; Zeng, ZW; Zhang, WQ; Zhang, YN | 1 |
| Baratashvili, N; Kandelaki, M; Samsonia, M | 1 |
| Avgerinos, KI; Chatzisotiriou, A; Haidich, AB; Lioutas, VA; Tsapas, A | 1 |
| Bohlooli, S; Moradi, A; Panahpour, H; Sadeghian, N; Shadman, J | 1 |
| Conwit, R; Eckstein, M; Hamilton, S; Kim-Tenser, M; Liebeskind, DS; Rosell, BJ; Sanossian, N; Saver, JL; Sharma, L; Shkirkova, K; Starkman, S | 1 |
| Akarachkova, ES; Vershinina, SV | 1 |
| Edomwonyi, NP; Idehen, H | 1 |
| Ishikawa, K; Kawai, M; Kikkawa, F; Morikawa, S; Ohno, Y; Sakakibara, K; Tanaka, K | 1 |
| Hatez, S | 1 |
| Conwit, R; Eckstein, M; Goldweber, R; Hamilton, S; Kramer, I; Liebeskind, DS; Moreau, G; Pratt, FD; Sanossian, N; Saver, JL; Starkman, S; Stratton, SJ; Sung, G | 1 |
| Aguilar, MI; Aoun, RJ; Bendok, BR; Demaerschalk, BM; Hamade, YJ; Zammar, SG | 1 |
| Alger, JR; Chen, C; Davis, SM; De Silva, DA; Kidwell, CS; Lees, KR; Muir, KW; Saver, JL; Starkman, S; Weir, CJ | 1 |
| Duan, WM; Duan, YF; Liu, C; Zhao, LR; Zhao, YF | 1 |
| Bertens, D; Dorhout Mees, SM; Rinkel, GJ; van den Bergh, WM; van der Worp, HB | 1 |
| Ali, LK; Conwit, R; Hamilton, S; Liebeskind, DS; Restrepo, L; Sanossian, N; Saver, JL; Starkman, S | 1 |
| Aleksoska, E; Cox, SF; Donnan, GA; Howells, DW; Macleod, MR; O'Collins, VE; Van Raay, L | 1 |
| McCaulley, JA; Pates, JA | 1 |
| Afshari, D; Moradian, N; Rezaei, M | 1 |
| Liang, H; Song, SL; Wang, YL | 1 |
| Garza, M | 1 |
| Goldstein, LB | 1 |
| Davis, S; Ford, I; Lees, KR; Muir, KW | 1 |
| Eckstein, M; Kidwell, C; Saver, JL; Starkman, S | 1 |
| Zivin, JA | 1 |
| Silverman, M | 1 |
| Gupta, VK | 1 |
| Antman, EM; Assmann, SF; Domanski, M; McKinlay, S; Norman, J; Platonov, P; Varshavsky, S | 1 |
| Antman, EM; Assmann, SF; Cooper, HA; Domanski, MJ; Hochman, JS; McKinlay, SM; Norman, J; Rosenberg, Y; Scott, JH | 1 |
| Lees, KR; Muir, KW; Ovbiagele, B; Saver, JL; Weir, CJ | 1 |
| Apperson-Hansen, C; Bhudia, SK; Blackstone, EH; Cosgrove, DM; Gillinov, AM; Lam, BK; Naugle, RI; Palumbo, RC; Petrich, J; Rajeswaran, J; Walton, E | 1 |
| Marder, VJ; Saver, JL; Starkman, S; Stewart, D | 1 |
| Walker, JJ | 1 |
| Ahmad, F; Li, Q; Shuaib, A; Yang, Y | 1 |
| Mitka, M | 1 |
9 review(s) available for magnesium sulfate and Apoplexy
| Article | Year |
|---|---|
Magnesium as a Neuroprotective Agent: A Review of Its Use in the Fetus, Term Infant with Neonatal Encephalopathy, and the Adult Stroke Patient.
Topics: Adult; Animals; Brain; Brain Diseases; Fetus; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Stroke | 2018 |
A meta-analysis of pharmacological neuroprotection in noncardiac surgery: focus on statins, lidocaine, ketamine, and magnesium sulfate.
Topics: Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ketamine; Lidocaine; Magnesium Sulfate; Neuroprotective Agents; Perioperative Period; Postoperative Complications; Stroke | 2018 |
Intravenous Magnesium Sulfate in Acute Stroke.
Topics: Administration, Intravenous; Brain Ischemia; Humans; Intracranial Hemorrhages; Magnesium Sulfate; Neuroprotective Agents; Stroke; Survival Rate; Treatment Outcome | 2019 |
[The role of magnesium in neuroprotection and neuroplasticity].
Topics: Animals; Humans; Magnesium; Magnesium Sulfate; Neuronal Plasticity; Neuroprotective Agents; Stroke | 2013 |
Management of eclampsia and stroke during pregnancy.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Cerebral Hemorrhage; Cooperative Behavior; Diagnosis, Differential; Eclampsia; Fatal Outcome; Female; Home Childbirth; Hospitals, General; Humans; Interdisciplinary Communication; Japan; Magnesium Sulfate; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Referral and Consultation; Risk Factors; Stroke; Surveys and Questionnaires; Survival Rate; Tomography, X-Ray Computed | 2013 |
Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.
Topics: Age Factors; Animals; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Magnesium Sulfate; Melatonin; Minocycline; Neuroprotective Agents; Rats; Severity of Illness Index; Stroke; Treatment Outcome | 2011 |
[The intervention treatment of neuroprotection for ischemic stroke].
Topics: Albumins; Animals; Brain Ischemia; Calcium Channel Blockers; Fibrinolytic Agents; Humans; Hypothermia, Induced; Magnesium Sulfate; Neuroprotective Agents; Stroke; Tissue Plasminogen Activator | 2012 |
Magnesium sulfate in prehospital care.
Topics: Acute Disease; Arrhythmias, Cardiac; Asthma; Emergency Medical Services; Emergency Treatment; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Meta-Analysis as Topic; Pre-Eclampsia; Pregnancy; Stroke | 2004 |
Severe pre-eclampsia and eclampsia.
Topics: Anticonvulsants; Antihypertensive Agents; Cesarean Section; Clinical Protocols; Eclampsia; Female; Fetal Monitoring; Fluid Therapy; Humans; Hypertension; Magnesium Sulfate; Maternal Mortality; Pre-Eclampsia; Pregnancy; Pulmonary Edema; Stroke | 2000 |
14 trial(s) available for magnesium sulfate and Apoplexy
| Article | Year |
|---|---|
Magnesium Sulfate and Hematoma Expansion: An Ancillary Analysis of the FAST-MAG Randomized Trial.
Topics: Cerebral Hemorrhage; Female; Hematoma; Humans; Magnesium; Magnesium Sulfate; Male; Retrospective Studies; Stroke; United States | 2022 |
The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Comorbidity; Drug Administration Schedule; Female; Heart Diseases; Hospitalization; Humans; Incidence; Los Angeles; Magnesium Sulfate; Male; Middle Aged; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2020 |
Protective Effects of Intravenous Magnesium Sulfate in Stroke Patients Receiving Amiodarone: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Amiodarone; Anti-Arrhythmia Agents; Humans; Magnesium Sulfate; Stroke | 2021 |
Paramedic Initiation of Neuroprotective Agent Infusions: Successful Achievement of Target Blood Levels and Attained Level Effect on Clinical Outcomes in the FAST-MAG Pivotal Trial (Field Administration of Stroke Therapy - Magnesium).
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Emergency Medical Technicians; Female; Follow-Up Studies; Humans; Magnesium; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Outcome Assessment, Health Care; Stroke | 2017 |
Subject Retention in Prehospital Stroke Research Using a Telephone-Based Physician-Investigator Driven Enrollment Method.
Topics: Ambulances; California; Cell Phone; Emergency Medical Services; Emergency Medical Technicians; Humans; Informed Consent; Magnesium Sulfate; Neuroprotective Agents; Patient Dropouts; Patient Selection; Research Personnel; Stroke; Time Factors; Treatment Outcome | 2019 |
Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
Topics: Acute Disease; Aged; Brain Ischemia; Double-Blind Method; Emergency Medical Services; Female; Hemorrhage; Humans; Infusions, Intravenous; Intracranial Hemorrhages; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Stroke; Time-to-Treatment | 2015 |
Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.
Topics: Acute Disease; Aged; Analysis of Variance; Blood Glucose; Cerebral Infarction; Diffusion Magnetic Resonance Imaging; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Magnesium Sulfate; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Patient Selection; Stroke; Treatment Outcome | 2009 |
Magnesium and headache after aneurysmal subarachnoid haemorrhage.
Topics: Analgesics; Analgesics, Opioid; Codeine; Female; Headache; Humans; Injections, Intravenous; Logistic Models; Magnesium Sulfate; Male; Middle Aged; Pain Measurement; Pirinitramide; Stroke; Subarachnoid Hemorrhage; Tramadol | 2010 |
Priority traffic.
Topics: Emergency Medical Services; Emergency Medical Technicians; Humans; Los Angeles; Magnesium Sulfate; Placebos; Stroke | 2004 |
Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.
Topics: Acute Disease; Aged; Confidence Intervals; Female; Humans; Infusions, Intravenous; Logistic Models; Magnesium Sulfate; Male; Neuroprotective Agents; Odds Ratio; Placebos; Prospective Studies; Stroke; Survival Analysis; Treatment Outcome | 2004 |
Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial.
Topics: Aged; Aged, 80 and over; Ambulances; Emergency Medical Services; Emergency Medical Technicians; Feasibility Studies; Female; Hospitalization; Humans; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Pilot Projects; Severity of Illness Index; Stroke; Treatment Outcome | 2004 |
Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.
Topics: Aged; Angioplasty; Calcium Channel Blockers; Demography; Female; Fibrinolytic Agents; Heart Failure; Humans; Hypertension; Incidence; Internationality; Magnesium Sulfate; Male; Middle Aged; Myocardial Infarction; Prevalence; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2004 |
Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial.
Topics: Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Depression; Female; Humans; Length of Stay; Magnesium Sulfate; Male; Memory; Mental Status Schedule; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Postoperative Complications; Principal Component Analysis; Stroke | 2006 |
Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator-induced thrombolysis.
Topics: Dose-Response Relationship, Drug; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; In Vitro Techniques; Magnesium Sulfate; Male; Neuroprotective Agents; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2006 |
17 other study(ies) available for magnesium sulfate and Apoplexy
| Article | Year |
|---|---|
The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study.
Topics: Acute Kidney Injury; Adult; Anticonvulsants; Antihypertensive Agents; Cesarean Section; Cohort Studies; Disseminated Intravascular Coagulation; Eclampsia; Female; Fetal Growth Retardation; Gestational Age; Headache; Hemolysis; Humans; Hypertension, Pregnancy-Induced; Intensive Care Units; Intensive Care Units, Neonatal; Labor, Induced; Liver Diseases; Logistic Models; Magnesium Sulfate; Nervous System Diseases; Perinatal Death; Postpartum Hemorrhage; Pre-Eclampsia; Pregnancy; Premature Birth; Proteinuria; Pulmonary Edema; Retrospective Studies; Severity of Illness Index; Stroke; Thrombocytopenia; Vision Disorders; Young Adult | 2021 |
[EVALUATION OF NEUROPROTECTIVE ACTIVITY OF COMPLEX IMPACT OF MAGNESIUM OF SULFATE, LAMOTRYGINE AND N-ACETYLCYSTEINE UNDER CONDITIONS OF COMBINED NORMOBARIC HYPOXIA WITH LIGATION OF RIGHT CAROTID ARTERY IN RATS].
Topics: Acetylcysteine; Administration, Oral; Animals; Animals, Outbred Strains; Brain Ischemia; Carotid Arteries; Cerebrovascular Disorders; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Injections, Intraperitoneal; Lamotrigine; Magnesium Sulfate; Male; Neuroprotective Agents; Rats; Stroke | 2018 |
Magnesium sulfate protects blood-brain barrier integrity and reduces brain edema after acute ischemic stroke in rats.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Brain Ischemia; Catalase; Disease Models, Animal; Glutathione Peroxidase; Lipid Peroxidation; Magnesium Sulfate; Male; Malondialdehyde; Neuroprotective Agents; Permeability; Rats; Rats, Sprague-Dawley; Stroke; Superoxide Dismutase | 2019 |
Cortical blindness in obstetric patients: case report of two different presentations.
Topics: Adult; Blindness, Cortical; Calcium Channel Blockers; Cesarean Section; Convalescence; Diagnostic Techniques, Ophthalmological; Eclampsia; Female; Humans; Magnesium Sulfate; Mood Disorders; Neurologic Examination; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Psychiatric Status Rating Scales; Stroke; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The beneficial failure of the FAST-MAG trial. Prehospital magnesium didn't help stroke patients, but we still learned a lot.
Topics: Clinical Trials, Phase III as Topic; Emergency Medical Services; Emergency Medical Technicians; Emergency Treatment; Humans; Los Angeles; Magnesium Sulfate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Treatment Failure | 2014 |
From Delivering the Patient to the Hospital to Delivering the Hospital to the Patient: Acute Stroke Therapy in an Ambulance.
Topics: Ambulances; Calcium Channel Blockers; Humans; Magnesium Sulfate; Stroke | 2015 |
Thiopental exaggerates ischemic brain damage and neurological deficits after experimental stroke in spontaneously hypertensive rats.
Topics: Anesthetics, Intravenous; Animals; Brain; Brain Ischemia; Chloral Hydrate; Disease Models, Animal; Dyskinesia, Drug-Induced; Magnesium Sulfate; Male; Methohexital; Pentobarbital; Random Allocation; Rats; Rats, Inbred SHR; Stroke; Thiopental; Time Factors; Treatment Outcome; Unconsciousness | 2009 |
Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials.
Topics: Aged; Calcium Channel Blockers; Cell Phone; Female; Humans; Informed Consent; Internet; Los Angeles; Magnesium Sulfate; Male; National Institutes of Health (U.S.); Physicians; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Time Factors; United States | 2009 |
Postpartum cerebral venous thrombosis.
Topics: Anticoagulants; Anticonvulsants; Brain; Female; Heparin; Humans; Hypertension; Levetiracetam; Magnesium Sulfate; Magnetic Resonance Imaging; Piracetam; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Seizures; Sinus Thrombosis, Intracranial; Stroke; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Young Adult | 2011 |
Evaluation of the intravenous magnesium sulfate effect in clinical improvement of patients with acute ischemic stroke.
Topics: Aged; Aged, 80 and over; Blood Pressure; Brain Ischemia; Endpoint Determination; Female; Humans; Injections, Intravenous; Intracranial Embolism; Intracranial Thrombosis; Magnesium; Magnesium Sulfate; Male; Middle Aged; Neurologic Examination; Sample Size; Stroke; Tomography, X-Ray Computed | 2013 |
Neuroprotective therapy for acute ischaemic stroke: down, but not out.
Topics: Acute Disease; Humans; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic; Research Design; Stroke; Treatment Outcome | 2004 |
SLOW-MAG.
Topics: Calcium Channel Blockers; Humans; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic; Stroke | 2004 |
Intravenous magnesium for neuroprotection in acute stroke: clinical hope versus basic neuropharmacology.
Topics: Humans; Magnesium Sulfate; Neuroprotective Agents; Stroke | 2004 |
Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Contraindications; Electrocardiography; Female; Heart Failure; Humans; Logistic Models; Magnesium Sulfate; Male; Multivariate Analysis; Myocardial Infarction; Prognosis; Recurrence; Risk Factors; Stroke; Thrombolytic Therapy | 2004 |
Effect of smoking status on outcome after acute ischemic stroke.
Topics: Aged; Brain Ischemia; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Randomized Controlled Trials as Topic; Smoking; Stroke; Treatment Outcome | 2006 |
Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Infusions, Intravenous; Intracranial Embolism; Magnesium Sulfate; Male; Rats; Rats, Wistar; Stroke; Survival Rate; Time Factors | 2000 |
News about neuroprotectants for the treatment of stroke.
Topics: Clinical Trials as Topic; Cytidine Diphosphate Choline; Excitatory Amino Acid Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnesium Sulfate; Neuroprotective Agents; Phosphatidylcholines; Stroke; Time Factors | 2002 |